✦ LIBER ✦

Early vs. late administration of glycoprotein IIb/IIIa inhibitors in primary percutaneous coronary intervention of acute ST-segment elevation myocardial infarction. A meta-analysis

✍ Scribed by G. Montalescot; M. Borentain; L. Payot; J.P. Collet; D. Thomas

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

AS-9: Thrombus Aspiration in Primary Per

✍ Jeong Hoon Kim; Byung Ok Kim; Kwang-Sil Kim; Choong-Won Goh; Young-Sup Byun; Sun 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 112 KB

Prospective evaluation of glycoprotein I

✍ P Lachance; J.-P. Déry; S Grenier; G Barbeau; B Noël; É Larose; J Rodés-Cabau; O 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 47 KB

AS-77: Clinical Benefits of Glycoprotein

✍ Doo Sun Sim 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 53 KB

Effectiveness and safety of glycoprotein

✍ Remi Kouz; Simon Kouz; Erick Schampaert; Stephane Rinfret; Jean-Claude Tardif; M 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 759 KB

Comparative Early and Late Outcomes Afte

✍ David A. Cox; Gregg W. Stone; Cindy L. Grines; Thomas Stuckey; Peter J. Zimetbau 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 164 KB

Timing of Glycoprotein IIb/IIIa Inhibito

✍ Pierluigi Tricoci; Eric D. Peterson; Anita Y. Chen; L. Kristin Newby; Robert A. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 164 KB